Form 4: Neuronetics Director Robert Cascella Increases Stake in Company
SEC Form 4
Director Robert Cascella recently purchased 70,000 shares of Neuronetics, Inc. common stock in two separate transactions.
Summary
- Robert Cascella, a director of Neuronetics, Inc., has increased his holdings in the company.
- On August 14, 2024, Cascella purchased 35,000 shares of common stock at a price of $0.79 per share.
- On August 15, 2024, he purchased an additional 35,000 shares at $0.88 per share.
- Following these transactions, Cascella directly owns 314,098 shares of Neuronetics common stock.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as a director is increasing their stake in the company, which is generally viewed favorably by investors.
Positives
- A director's increased investment in the company may signal confidence in its future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company's prospects are optimistic about its future.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Robert Cascella purchased 35,000 shares of common stock at $0.79 per share. |
| 08/15/2024 | Robert Cascella purchased 35,000 shares of common stock at $0.88 per share. |
| 08/16/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.